Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | ||||||
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | ||||||
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | ||||||
| 6 | Public support. Subtract line 5 from line 4. | ||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | ||||||
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | ||||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10 | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | 257,682 | 153,178 | 573,250 | 184,155 | 51,856 | 1,220,121 |
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | 4,653,989 | 4,949,197 | 5,471,362 | 7,323,031 | 8,943,215 | 31,340,794 |
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | 4,911,671 | 5,102,375 | 6,044,612 | 7,507,186 | 8,995,071 | 32,560,915 |
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | 32,560,915 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | 4,911,671 | 5,102,375 | 6,044,612 | 7,507,186 | 8,995,071 | 32,560,915 |
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | 13,533 | 15,038 | 11,164 | 11,718 | 14,528 | 65,981 |
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | 13,533 | 15,038 | 11,164 | 11,718 | 14,528 | 65,981 |
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | 4,925,204 | 5,117,413 | 6,055,776 | 7,518,904 | 9,009,599 | 32,626,896 |
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2022 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2022 |
(iii) Distributable Amount for 2022 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2022 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2022 (reasonable cause required-- explain in Part VI).
See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2022: | ||||
| a From 2017....... | ||||
| b From 2018....... | ||||
| c From 2019....... | ||||
| d From 2020....... | ||||
| e From 2021....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2022 distributable amount | ||||
|
i
Carryover from 2017 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2022 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2022 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2022, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2022. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2023. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2018..... | ||||
| b Excess from 2019..... | ||||
| c Excess from 2020..... | ||||
| d Excess from 2021..... | ||||
| e Excess from 2022..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| FORM 990, PAGE 2, PART III, LINE 4A | RESEARCH: AT THE HEART OF THE RIORDAN CLINIC'S DAY-TO-DAY WORK AND LONG-TERM VISION IS THE RIORDAN CLINIC RESEARCH INSTITUTE. CONSISTING OF A SMALL BUT DEDICATED GROUP OF SCIENTISTS WHO ARE PASSIONATE ABOUT THEIR WORK, THE RIORDAN CLINIC RESEARCH INSTITUTE FOCUSES RESEARCH IN AREAS OF NUTRITIONAL MEDICINE AND NATURAL THERAPEUTICS. BECAUSE OF THE CLOSE RELATIONSHIP BETWEEN OUR RESEARCH TEAM AND THE PHYSICIANS AT THE RIORDAN CLINIC, WE ARE ABLE TO TARGET OUR RESEARCH TOWARD INNOVATIONS THAT WILL BE DIRECTLY BENEFICIAL TO RIORDAN CLINIC PATIENTS. THE RCRI OPERATES INDEPENDENTLY OF SPECIAL INTERESTS: IT NEITHER SOLICITS NOR ACCEPTS TAX-DERIVED FUNDS. ALL OF ITS RESEARCH FUNDING COMES FROM PRIVATE DONATIONS FROM INDIVIDUALS,CORPORATIONS, AND FOUNDATIONS. RESULTS OF THE RCRI'S RESEARCH ARE PRESENTED DURING LECTURES AND AT THE CONFERENCES, PUBLISHED IN PEER- REVIEWED JOURNALS, AND DESCRIBED ON THE CLINICS'S WEBSITE. THE RIORDAN CLINIC RESEARCH INSTITUTE WORKS TO DEVELOP NUTRIENT-BASED THERAPIES THAT RESOLVE PATHOLOGY WITHOUT HARMING NORMAL TISSUES. WE HAVE LONG BEEN A LEADER IN RESEARCH CONCERNING THE USE OF VITAMIN C IN CANCER THERAPY, AND HAVE EXTENSIVE EXPERIENCE IN DEVELOPING ALTERNATIVE THERAPIES FOR CANCER. OUR RESEARCH IN 2022 FOCUSED ON THE FOLLOWING AREAS (A MORE IN DEPTH REPORT IS AVAILABLE BY REQUEST): -EFFECTS OF MICRONUTRIENT SUPPLEMENTATION ON CONCENTRATIONS OF VITAMINS AND MINERALS, INFLAMMATION AND CARDIOVASCULAR RISK. -EFFECT OF HIGH DOSE VITAMIN C ON EPSTEIN-BARR VIRAL INFECTION. -THE RIORDAN CLINIC INTRAVENOUS VITAMIN C PROTOCOL AND BACKGROUND RESEARCH. -THE ROLE OF MITOCHONDRIA IN CANCER AND OTHER CHRONIC DISEASES. BIOENERGETICS OF HUMAN CANCER CELLS AND NORMAL CELLS DURING PROLIFERATION AND DIFFERENTIATION. -MODULATION OF CYTOKINES IN CANCER PATIENTS BY INTRAVENOUS ASCORBATE THERAPY. -BACTERIAL EXTRACTS: BIOLOGICAL RESPONSE MODIFIERS BASED ON BACTERIAL CELL WALL CARBOHYDRATES. CLINIC: AT RIORDAN CLINIC, WE WORK WITH YOU, AS A CO-LEARNER, TO RESTORE, IMPROVE, OR MAINTAIN YOUR HEALTH. WE BELIEVE IN REAL HEALTH, AND BY UNDERSTANDING YOUR INDIVIDUAL BIOCHEMICAL MAKE-UP WE ARE ABLE TO CREATE A UNIQUE HEALTH PATH FOR YOU. WE FOCUS ON NUTRITION THROUGH NUTRIENT TESTING AND WE ARE DEDICATED TO RESEARCH. THROUGH TESTING, THERAPIES, SERVICES AND NUTRIENTS WE WILL INDIVIDUALIZE A JOURNEY TO ENSURE THAT YOU FEEL YOUR ABSOLUTE BEST. THE RIORDAN CLINIC HAS CARED FOR INDIVIDUALS WITH A FOCUS ON HEALTH, RATHER THAN SICKNESS. WE BELIEVE IN THE IMPORTANCE OF LOOKING AT THE ROOT CAUSE OF ILLNESS, RATHER THAN TREATING SYMPTOMS. WE SUCCESSFULLY TREAT A WIDE VARIETY OF SUSTAINED ILLNESSES INCLUDING, BUT NOT LIMITED TO: CANCER, HEART DISEASE, CHRONIC FATIGUE SYNDROME, FIBROMYALGIA, AND DIABETES. SOME OF OUR MOST ENCOURAGING SUCCESS STORIES ARE WITH PATIENTS WHO HAVE A VARIETY OF LONG-TERM SYMPTOMS, BUT HAVE BEEN UNABLE TO GET A DIAGNOSIS. WE SEEK TO IDENTIFY THE UNDERLYING CAUSES OF ILLNESS AND CORRECT THEM USING NUTRIENT BALANCING AND OTHER THERAPIES. SYMPTOMS LIKE FATIGUE, RASH, CONSTIPATION, STIFFNESS, SWELLING, DEPRESSION, AND MANY OTHERS, ARE THE MANIFESTATION OF AN UNBALANCED CHEMISTRY WITHIN THE BODY. AT THE RIORDAN CLINIC, WE KNOW THAT THE NUTRIENTS IN OUR BODY CONTROL OUR CHEMISTRY, AND IF OUR INVENTORY IS LOW OR IN EXCESS OF SOME NUTRIENTS, SYMPTOMS ARE INEVITABLE. FOR THIS REASON, OUR PATIENTS, CALLED CO-LEARNERS, START WITH A BASELINE NUTRIENT INVENTORY PANEL ORDERED SO THAT THE DOCTORS CAN LEARN MORE ABOUT THEIR INDIVIDUALITY. OUR APPROACH IS TO TREAT THE WHOLE PERSON, BEGINNING WITH A THOROUGH REVIEW OF MEDICAL HISTORY AND A COMPREHENSIVE PATIENT EVALUATION. THIS YIELDS A HIGHLY CUSTOMIZED HOLISTIC TREATMENT PLAN THAT WILL PUT YOU ON THE PATH TO BETTER HEALTH. AS A PATIENT AT THE RIORDAN CLINIC, YOU WILL BE FULLY INVOLVED IN THE DISCOVERY PROCESS OF GETTING WELL. BY TAKING AN ACTIVE ROLE IN YOUR RECOVERY, YOU WILL UNDERSTAND THE SYSTEMIC CAUSES OF YOUR ILLNESS BETTER, THUS ENACTING A POSITIVE IMPACT ON YOUR HEALTH. |
| FORM 990, PAGE 2, PART III, LINE 4B | LABORATORY: THE ON-SITE RIORDAN CLINIC LABORATORY WAS ESTABLISHED IN 1975, ORIGINALLY AS THE BIO-CENTER LAB. OUR LAB HAS DEDICATED ITSELF TO PROVIDING ACCURATE CLINICAL ANALYSIS FOCUSING ON NUTRITIONAL LEVELS. OUR SPECIALTIES INCLUDE TESTING FOR PYRROLES, HISTAMINE, CYTOTOXIC FOOD SENSITIVITIES, PARASITOLOGY, ANALYSIS OF RED BLOOD CELL FATTY ACIDS AND MINERALS, ALONG WITH MANY VITAMINS. WE HAVE DONE EXHAUSTIVE RESEARCH TO DETERMINE WHICH TEST METHODOLOGIES AND SPECIMEN TYPES WILL YIELD THE MOST CLINICALLY SIGNIFICANT RESULTS. WE HAVE BEEN PERFORMING AND INNOVATING MANY OF OUR SPECIALTY TESTS FOR MORE THAN 30 YEARS. OUR HISTAMINE AND PYRROLES TESTS HAVE BEEN OFFERED FOR 38 YEARS AND ARE STILL TWO OF THE MOST REQUESTED REFERENCE TESTS WE PERFORM. IN FACT, WE ARE PROUD TO BE THE LABORATORY THAT MANY OTHER LABS CHOOSE TO DO THEIR PYRROLES TESTING. THE FUNCTION OF OUR LABORATORY IS TWO-FOLD: TO PROVIDE IN-HOUSE PATIENTS WHO COME FOR TREATMENT WITH ACCURATE STATE OF THE ART LABORATORY ANALYSIS AND TO PROVIDE DIAGNOSTIC SERVICES FOR PHYSICIANS AND HOSPITALS THROUGHOUT THE COUNTRY. IN BOTH CASES, WE PROVIDE DOCTORS RELEVANT BIOCHEMICAL IMPAIRMENT INFORMATON TO INCREASE DIAGNOSTIC ACCURACY. |
| FORM 990, PAGE 2, PART III, LINE 4C | EDUCATION: THE RIORDAN CLINIC HAS A VARIETY OF EVENTS FROM OUR BI-ANNUAL IVC & CANCER SYMPOSIUMS TO LUNCH AND LECTURES. OUR APPROACH IS ONE OF INTEGRATIVE MEDICINE, WHERE WE MAXIMIZE THE BENEFITS OF BOTH ORTHOMOLECULAR AND CONVENTIONAL MEDICINE TO ACHIEVE RESULTS. SINCE CO-LEARNERS AT THE RIORDAN CLINIC HAVE A VESTED INTEREST IN THE RESEARCH AND DISCOVERY PROCESS, THEY ATTAIN THE ULTIMATE FORM OF HEALING: HOPE. THE RIORDAN CLINIC SYMPOSIUM (HELD BI-ANNUALLY, THE NEXT IS SCHEDULED FOR FALL 2023) EXPLORES THE UNDERLYING CAUSES OF CANCER, WITH THE INTENT OF ELUCIDATING NEW WAYS TO TREAT THE DISEASE IN A NON-TOXIC FASHION. ACADEMY SPEAKERS REPRESENT A GROWING FIELD OF CANCER PIONEERS WHO HAVE FOUND THAT IVC IS A POWERFUL ADJUNCT IN THE CARE OF CANCER PATIENTS. ALTHOUGH INTENDED FOR MEDICAL PROFESSIONALS, THE LECTURES ALSO SERVE TO INFORM INTERESTED "CANCER CO- LEARNERS" WHO SEEK HELP FOR THEMSELVES AND THEIR FRIENDS AND FAMILY THROUGH A BETTER QUALITY OF LIFE. THE RIORDAN CLINIC IVC ACADEMY IS PACKED WITH TWO DAYS OF LECTURES, CONVERSATIONS, AND CAMARADERIE WITH OTHER MEDICAL PROFESSIONALS WHO USE HIGH-DOSE VITAMIN C IN THEIR PRACTICES. ON FRIDAY THERE WILL BE MULTIPLE SPEAKERS LAYING OUT THE HISTORY AND STEPS BEHIND THE PROPER USE OF THE RIORDAN IVC PROTOCOL. THE ACADEMY LECTURES WILL SERVE AS AN EXCELLENT OPPORTUNITY FOR IVC PRACTITIONERS TO BECOME MORE INVOLVED WITH IVC THERAPY, ADJUNCT THERAPIES AND EXPOUND NEW APPROACHES TO TREATING CANCER. LECTURES CONTINUE INTO SATUDAY AND WE WILL CONCLUDE THE EVENT WITH THE RIORDAN IVC CERTIFICATION TEST, WHICH WILL BE GRADED AND RETURNED BEFORE DISMISSAL. THE RIORDAN RESOURCE LIBRARY ORIGINALLY FUNDED BY THE MABEE FAMILY, PROVIDES COMPREHENSIVE INFORMATION ABOUT THE HUMAN CONDITION. THE LIBRARY IS AVAILABLE TO ANYONE WHO WISHES TO EXPAND THEIR KNOWLEDGE ON A PARTICULAR MEDICAL SUBJECT. SOME OF THE RESOURCES AVAILABLE TO ASSIST YOU IN YOUR RESEARCH INCLUDE MORE THAN 3,000 BOOKS, 1,200 VIDEOS AND 3,200 AUDIO TAPES. ADDITIONALLY, OUR JOURNAL ARTICLE COLLECTION CONTINUES TO GROW AS NEW RESEARCH IN VARIOUS FIELDS BREAKS TO THE SURFACE. MORE THAN 10,000 ARTICLES HAVE BEEN COLLECTED FROM SOURCES OUTSIDE OUR LIBRARY. AS A RESEARCH LIBRARY, YOU'RE WELCOME TO UTILIZE OUR COLLECTION SOLEY ON SITE. SUPPLEMENT YOUR RESEARCH AND FINDINGS WITH INTERNET ACCESS. THE MAYBEE LIBRARY WILL CONTINUE TO BE CUTTING EDGE BASED ON PRIVATE DONATIONS FROM INDIVIDUALS, CORPORATIONS, AND FOUNDATIONS. SINCE CO-LEARNERS ARE ENCOURAGED TO SEEK OUT INFORMATION ABOUT THEIR INDIVIDUAL NEEDS, THE RIORDAN RESOURCE LIBRARY PLAYS A SIGNIFICANT ROLE IN THAT PROCESS. |
| FORM 990, PAGE 6, PART VI, LINE 11B | THE ORGANIZATION'S 990 IS REVIEWED BY A MEMBER OF THE BOARD, THE CHIEF EXECUTIVE OFFICER AND CHIEF OPERATING OFFICER PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. |
| FORM 990, PAGE 6, PART VI, LINE 12C | THE ORGANIZATION HAS A CONFLICT OF INTEREST POLICY. ALL OFFICERS AND KEY EMPLOYEES ARE AWARE OF THE POLICY AND ANY POTENTIAL CONFLICTS ARE ADDRESSED THROUGHOUT THE YEAR. |
| FORM 990, PAGE 6, PART VI, LINE 15A | OFFICERS AND KEY EMPLOYEE COMPENSATION IS REVIEWED BY THE ORGANIZATION'S BOARD ON AN ANNUAL BASIS. SALARY RANGES ARE APPROVED FOR VARIOUS STAFF POSITIONS BY THE BOARD AS WELL. |
| FORM 990, PAGE 6, PART VI, LINE 15B | THE ORGANIZATIONS OFFICERS AND KEY EMPLOYEE COMPENSATION IS REVIEWED BY THE ORGANIZATION'S BOARD ON AN ANNUAL BASIS. SALARY RANGES ARE APPROVED FOR VARIOUS STAFF POSITIONS BY THE BOARD AS WELL. |
| FORM 990, PAGE 6, PART VI, LINE 19 | THE ORGANIZATION MAKES THESE ITEMS AVAILABLE TO THE PUBLIC UPON REQUEST. |
| Software ID: | |
| Software Version: |